Drug Approval | May 20, 2023
Granules India received ANDA approval for Venlafaxine ER capsules
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The facility will have a capacity to manufacture upto 3 million tubes monthly
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Subscribe To Our Newsletter & Stay Updated
